Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 9.0B | 9.0B | 9.4B | 8.5B |
Cost of revenue | 2.4B | 2.4B | 2.4B | 2.3B |
Gross profit | 6.6B | 6.6B | 6.9B | 6.2B |
Operating expense | ||||
Research & development | 1.6B | 1.7B | 1.7B | 1.6B |
Selling general and admin | 2.5B | 2.6B | 2.9B | 2.5B |
Other operating expenses | 11M | 8M | 54M | 22M |
Operating income | 2.5B | 2.3B | 2.3B | 2.2B |
Non operating interest income | ||||
Income | 317M | 405M | 579M | 240M |
Expense | 268M | 280M | 305M | 241M |
Other income expense | -21M | 10M | -406M | -10M |
Pretax income | 2.5B | 2.5B | 2.2B | 2.2B |
Tax provision | 753M | 672M | 591M | 710M |
Net income | 1.7B | 1.8B | 1.6B | 1.4B |
Basic EPS | 1.5 | 1.5 | 1.4 | 1.3 |
Diluted EPS | 1.4 | 1.5 | 1.4 | 1.2 |
Basic average shares | 1.2B | 1.2B | 1.2B | 1.2B |
Diluted average shares | 1.2B | 1.2B | 1.2B | 1.2B |
EBITDA | 3.1B | 3.1B | 3.4B | 2.7B |
Net income from continuing op. | 1.7B | 1.8B | 1.6B | 1.4B |
Minority interests | -52M | -16M | -15M | 23M |
Preferred stock dividends | — | — | — | — |